|
Statements of Operations (USD $)
In Thousands, except Share data, unless otherwise specified |
3 Months Ended | 6 Months Ended | 90 Months Ended | ||
|---|---|---|---|---|---|
|
Jun. 30, 2012
|
Jun. 30, 2011
|
Jun. 30, 2012
|
Jun. 30, 2011
|
Jun. 30, 2012
|
|
| Grant Revenue | $ 650 | ||||
| Operating expenses: | |||||
| Research and development | 3,359 | 3,703 | 6,813 | 5,277 | 68,071 |
| Acquired in-process research and development | 5,500 | ||||
| Selling, general and administrative | 2,420 | 2,530 | 4,807 | 4,500 | 28,822 |
| Total operating expenses | 5,779 | 6,233 | 11,620 | 9,777 | 102,393 |
| Loss from operations | (5,779) | (6,233) | (11,620) | (9,777) | (101,743) |
| Interest income | 6 | 17 | 16 | 42 | 662 |
| Interest expense | (395) | (249) | (848) | (452) | (8,671) |
| Loss before tax benefit | (6,168) | (6,465) | (12,452) | (10,187) | (109,752) |
| Income tax benefit | 698 | ||||
| Net loss | $ (6,168) | $ (6,465) | $ (12,452) | $ (10,187) | $ (109,054) |
| Basic and diluted net loss per common share (in dollars per share) | $ (0.42) | $ (0.44) | $ (0.85) | $ (0.70) | |
| Weighted average basic and diluted common shares outstanding (in shares) | 14,736,809 | 14,561,519 | 14,734,696 | 14,557,655 | |